Ann: Bionomics' PTSD Trial Results, page-33

I listened to most of the conference call, but my NBN locked up and I was thrown off half way through the Q&A. Sounds like PTSD is finished for BNC210. The Placebo group caught up to the patients under test. Now all eyes turn to the Agitated behavioral disturbance in elderly patients trial. BNC210 is better suited to Depression and Anxiety disorders than PTSD. I hope they put a recording of the call up later. Will have to hear what their strategic review comes up with when they present the results at the AGM. Main issue now is cash burn, although that wasn't talked about during the conference call.